Adial Pharmaceuticals Inc (ADIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,584 | 5,881 | 4,606 | 5,915 | 2,366 |
| TOTAL | $4,803 | $6,181 | $5,014 | $6,079 | $2,629 |
| Non-Current Assets | |||||
| Investments And Advances | 422 | 490 | 643 | 720 | 819 |
| Intangibles | 3 | 3 | 3 | 3 | 3 |
| TOTAL | $424 | $493 | $646 | $723 | $822 |
| Total Assets | $5,227 | $6,673 | $5,660 | $6,802 | $3,451 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 574 | 655 | 556 | 671 | 532 |
| Accrued Expenses | 937 | 742 | 599 | 540 | 759 |
| TOTAL | $1,510 | $1,397 | $1,155 | $1,211 | $1,325 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,510 | $1,397 | $1,155 | $1,211 | $1,325 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,144 | 1,428 | 960 | 873 | 316 |
| Common Shares | 2 | 1 | 24 | 22 | 7 |
| Retained earnings | -91,995 | -89,973 | -87,976 | -86,183 | -84,224 |
| TOTAL | $3,717 | $5,277 | $4,505 | $5,591 | $2,127 |
| Total Liabilities And Equity | $5,227 | $6,673 | $5,660 | $6,802 | $3,451 |